Literature DB >> 32656830

Editorial: pancreatic cancer risk in inflammatory bowel diseases-it's all relative.

Ariela K Holmer1, Siddharth Singh1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32656830      PMCID： PMC7987110          DOI： 10.1111/apt.15877

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  4 in total

Review 1.  ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

Authors:  Francis A Farraye; Gil Y Melmed; Gary R Lichtenstein; Sunanda V Kane
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

2.  Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Authors:  Annika Bergquist; Anders Ekbom; Rolf Olsson; Dan Kornfeldt; Lars Lööf; Ake Danielsson; Rolf Hultcrantz; Stefan Lindgren; Hanne Prytz; Hanna Sandberg-Gertzén; Sven Almer; Fredrik Granath; Ulrika Broomé
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

3.  Inflammatory bowel disease and pancreatic cancer: a Scandinavian register-based cohort study 1969-2017.

Authors:  Åsa H Everhov; Rune Erichsen; Michael C Sachs; Lars Pedersen; Jonas Halfvarson; Johan Askling; Anders Ekbom; Jonas F Ludvigsson; Henrik Toft Sørensen; Ola Olén
Journal:  Aliment Pharmacol Ther       Date:  2020-05-15       Impact factor: 8.171

4.  British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.

Authors:  Michael Huw Chapman; Douglas Thorburn; Gideon M Hirschfield; George G J Webster; Simon M Rushbrook; Graeme Alexander; Jane Collier; Jessica K Dyson; David Ej Jones; Imran Patanwala; Collette Thain; Martine Walmsley; Stephen P Pereira
Journal:  Gut       Date:  2019-06-01       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.